Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and their associated cas genes constitute a bacterial and archaeal defence mechanism against exogenous nucleic
acids [23]. AZD5582 mouse The majority of archaea and approximately half of bacterial genomes contain CRISPR loci [24]. CRISPR loci consist of unique sequences (spacers) that intercalate between short conserved repeat sequences. The spacer sequences often originate from invading viruses and plasmids [25, 26]. The CRISPR/Cas defence mechanism relies on RNA interference that prevents bacteriophage infection and plasmid conjugation, thus restricting two routes of HGT [27]. Analyses of CRISPR sequences have been used in a variety of applications including strain genotyping and epidemiological study, drug discovery detection of evolutionary events and bottlenecks, investigation of the history of virus exposure, and host population dynamics, providing insights into the dominant routes of HGT [28–32]. The current study targeted the detection and analysis of CRISPR loci in the genomes of 17 G. vaginalis strains isolated from the vaginal tracts of women diagnosed with BV [18], and also in the genomes of 21 G. vaginalis strains deposited in the NCBI genome database. In the current study, we examined the origins of CRISPR spacers representing the immunological memory of G. vaginalis strains, and we hypothesised about the impact of CRISPR/Cas on the emergence of genetic variability
of G. vaginalis strains. Also, we demonstrated the restricted distribution of the CRISPR loci among the G. vaginalis strains. Methods G. vaginalis strains Seventeen G. vaginalis strains isolated from 4EGI-1 clinical specimens obtained from the vaginal tracts of women diagnosed with BV were used in this study [18]. The isolates had been Gemcitabine previously genotyped/biotyped and characterised with respect to the main known virulence factors, namely vaginolysin and sialidase [18]. Three completely sequenced G. vaginalis genomes (ATCC14019, CP002104.1; 409–05, CP001849.1; and HMP9231, CP002725.1) and 18 G. vaginalis draft genomes were retrieved from the NCBI genome database
(http://www.ncbi.nlm.nih.gov/genome/genomes/1967). The accession numbers of the draft genomes are listed in Additional file 1. CRISPR amplification and sequencing Primers for CRISPR amplification were designed by genomic comparison of the CRISPR flanking regions of G. vaginalis strains ATCC 14019, 5–1, AMD, 409–05, 41V, 101, and 315A. Three different sets of primers; Cas-1-1fw, Cas-3-1fw, CR-1rev, CR-2rev and CR-3rev; were used for the amplification of the CRISPR regions (Additional file 2). PCR was performed in a 50-μl reaction mixture containing 0.2 μM each primer, 20 ng genomic DNA and 1.5 U Long PCR Enzyme Mix (Thermo Scientific Fermentas, Vilnius, Lithuania). The reaction mixture was subjected to 28 cycles of denaturation at 94°C for 30 s, primer annealing at 50°C for 40 s, and extension at 72°C for 3 min.
No related posts.